ORPHA:1436
X-linked skeletal dysplasia-intellectual disability syndrome
Also known as: Christian syndrome
Publications
604
Trials
0
Interventional, condition-specific
Researchers
943
Distinct authors in sample
Gene link
—
Readiness
3/6
Stages with a signal
Clinical definition (Orphanet)
A rare spondylodysplastic characterized by skeletal anomalies, including short stature, ridging of the metopic suture, a fusion of cervical vertebrae, thoracic hemivertebrae, scoliosis, sacral hypoplasia and short middle phalanges. Patients also had a moderate and abducens palsies. Glucose intolerance and imperforate anus were also described. There have been no further descriptions in the literature since 1977.
How rare: <1 / 1 000 000 — fewer than one in a million. In a city the size of Kolkata, that might mean on the order of fifteen people.
Cross-references
Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.
- MONDO:0010668
- MeSH:C564101
- OMIM:309620
- UMLS:C1839729
Additional Mondo synonyms (1)
mental retardation-skeletal dysplasia
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
3/6 stages with a signal
No specific-condition interventional trial, but broader-category trials exist — discuss eligibility with a clinician.
- Gene identifiedNot found
No GenCC disease–gene assertion in this build
- LiteraturePresent
604 matched papers (46 in last 10 years) Source
- Phenotype characterisedPresent
21 HPO annotations (e.g. Scoliosis; Thoracic hemivertebrae; Abducens palsy) Source
- Animal modelNot found
No Alliance genotype “model of” associations via Monarch for these Mondo IDs
- Orphan designationNot found
No FDA or EMA orphan-drug designation matched this disease via UMLS or preferred name Source
- Interventional trialPartial
None under the specific name; 1 for broader category skeletal dysplasia
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Not yet — the cause hasn't been pinned down in GenCC.
No strong gene–disease assertion joined for this Orphanet entity.
Phenotypes (Monarch / HPO)
21
Associated phenotypes · MONDO:0010668
- Scoliosis
- Thoracic hemivertebrae
- Abducens palsy
- Skeletal dysplasia
- Anal atresia
Showing 5 of 21 — open Monarch for the full list.
Animal models (Monarch / Alliance)
None returned for this Mondo ID. Empty here is not proof that no model organism work exists under another name or gene.
Monarch fetch 2026-07-29
Therapies
Designations, candidates, and chemicals
FDA OOPD and EMA orphan designations, Open Targets clinical candidates, and CTD chemical associations via MyDisease.info. These never change the interventional-trial headline.
Orphan designation (FDA · EMA)
No designation matched this disease via UMLS or preferred name on the FDA OOPD mirror or EMA orphan register. Absence here is not proof that none exists under another wording.
Open Targets candidates
No drugs or clinical candidates returned for this Mondo ID on Open Targets.
CTD chemicals (MyDisease.info)
No CTD chemical associations returned for this Mondo ID.
Literature
Is anyone studying this?
604
604 papers have been published on this condition. That is a real research literature — still far smaller than common diseases (breast cancer: over 700,000 papers). Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=3967) is 59.
604 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 59 (publications denominator n=3967).
46 in the last 10 years · low confidence
Phrase hits: 604 · MeSH hits: 0
Who's working on it?
943
Distinct author names in 200 sampled papers — named people below.
Who's working on it?
No interventional trial matched this name; these authors publish on it in the sampled literature — a practical starting point for contact.
- 01Goldberg-Stern H3 papers · 2012
Felsenstein Research Center, Beilinson Medical Center, Petah Tiqva, Israel.
Papers in Europe PMC - 02
- 03Pedersen OB3 papers · 2023
Department of Clinical Immunology, Zealand University Hospital, Køge, Denmark.
Papers in Europe PMC - 04Abrami F2 papers · 1984Papers in Europe PMC
- 05Appicciafuoco A2 papers · 1984Papers in Europe PMC
- 06Bédi J2 papers · 1977Papers in Europe PMC
- 07Blanchet-Bardon C2 papers · 1982Papers in Europe PMC
- 08Caraballo R2 papers · 2021
Department of Neurology, Hospital de Pediatría "Prof. Dr. Juan P Garrahan", Buenos Aires, Argentina. Electronic address: robertohcaraballo@gmail.com.
Papers in Europe PMC - 09Chiavacci G2 papers · 1984Papers in Europe PMC
- 10Delmas PF2 papers · 1982Papers in Europe PMC
Clinical research
Is a treatment being tested?
0
interventional trials for this specific condition
No interventional trial testing a treatment matched this specific condition name on ClinicalTrials.gov (observational studies and pan-disease registries are listed separately when present). 1 trial are registered for skeletal dysplasia, the broader category — shown separately because they may or may not enrol this specific subtype.
Data as of 11 September 2026 · last trial check 11 September 2026
No matched interventional trials. This is true for 77.2% of diseases in the trials denominator (5501 of 7126). Here are the researchers publishing on it.
low confidence · 38.6th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
No interventional trial testing a treatment was found for this specific condition name on ClinicalTrials.gov.
1 interventional trial matched skeletal dysplasia, the broader category — listed below. Those studies are not counted in the condition-specific total.
Broader category: skeletal dysplasia
1
Interventional trials for the parent category, exclusive of NCT IDs already counted above. Eligibility for this subtype is not guaranteed.
Worth raising with a clinician. How we count trials.
Other registries (secondary)
Broader net from EU CTIS, ISRCTN, and ICTRP when available — deduped against ClinicalTrials.gov IDs already counted above. Dual-model LLM relevance gates what we keep. These rows are not added to the interventional headline.
raw 29 · after dedupe 29 · already on CT.gov 0 · kept 0 · parent 0 · uncertain 29 · dropped 0 · fetched 2026-07-29
Source notes: ictrp: Error: ICTRP public search unavailable (WHO portal is SPA-only; SOAP needs partnership). Tried: https://apps.who.int/tri
No secondary-registry studies passed dual-model relevance for this condition name (after dedupe).
Uncertain / not reviewed (29)
- isrctn·ISRCTN69111582·Not yet recruiting·Dexmedetomidine to improve neurologic injury of patients after out-of-hospital cardiac arrest
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN12510191·Not yet recruiting·A feasibility study of a smartphone app to support mental well-being in people with Long COVID
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN15819396·Recruiting·A Phase I/IIa trial of KJ-103 in solid cancers
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN74492936·Recruiting·Impact of a device that continuously measures glucose levels and patient education using written information and a consultation with a physician specialising on diabetes on patients with prediabetes identified by point-of-care tests in community pharmacies
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN70040289·No longer recruiting·Does placental growth factor testing improve outcomes for women with suspected preterm pre-eclampsia in low- and middle-income countries?
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN10914527·No longer recruiting·Testing how light resistance exercises with blood flow restriction can help treat tennis elbow: a controlled study
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN14770806·No longer recruiting·Innovative management practices to enhance hospital quality and save lives in Malawi
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN98886991·No longer recruiting·Electrical stimulation of the throat for swallowing difficulties after stroke
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN83842641·Recruiting·A trial assessing preoperative chemotherapy in patients with locally advanced but operable colon cancer
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN79815558·No longer recruiting·COV-COMPARE: A study to compare the VLA2001 and AZD1222 vaccines against COVID-19 in adults
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN17375500·No longer recruiting·Prevention of delirium (mental confusion) in intensive care using low dose risperidone
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN14990068·No longer recruiting·Zurich Coronavirus Cohort: an observational study to determine long-term clinical outcomes and immune responses after coronavirus infection (COVID-19), assess the influence of virus genetics, and examine the spread of the coronavirus in the population of the Canton of Zurich, Switzerland
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN15115586·No longer recruiting·Improving recovery in patients with stroke following brain hemorrhage (bleeding) using a blood pressure measuring machine
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN77314261·No longer recruiting·The impact of anti-diabetic drugs on the outcomes of heart attacks
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN36834159·No longer recruiting·IgA nephropathy study in Indians
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN43221600·No longer recruiting·Pilot study for the evaluation of a combined psycho- and physiotherapeutic treatment program for patients with chronic pelvic pain syndrome (CPPS)
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN10900733·No longer recruiting·Short course daily prednisolone therapy at the time of upper respiratory tract infection in children with relapsing steroid sensitive nephrotic syndrome: the PREDNOS 2 study
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN89514817·No longer recruiting·Obeticholic acid in patients with primary biliary cirrhosis
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN19604441·No longer recruiting·Probiotics for the prevention of antibiotic-associated diarrhoea and Clostridium difficile associated diarrhoea
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN10288268·No longer recruiting·Procalcitonin to guide duration of antibiotic therapy in intensive care patients
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN84835351·No longer recruiting·BIOScavenger Therapy in Organophosphate Poisoning
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN30870177·No longer recruiting·Mono-centred, randomised, placebo-controlled, double-blind parallel-arm study on the effect of Conjugated Linoleic Acid (CLA) on endothelial function and (postprandial) metabolic parameters in overweight men
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN70547688·No longer recruiting·Intervention study on the effect of quercetin on biomarkers for cardiovascular syndrome in patients with different apolipoprotein E (ApoE) isoforms
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN90960030·No longer recruiting·Effect of Functional milk product On the Metabolic Syndrome II
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN91188075·No longer recruiting·Monocentered, randomised, placebo-controlled, double-blind cross-over study on the effect of Conjugated Linoleic Acid (CLA) on fasting and postprandial metabolic parameters and endothelial function in men with PPARγ2 P12A polymorphism and controls
skipped — LLM skipped (--skip-llm)
Where to find support
Condition-specific patient organisations, when Orphanet lists them, are on the disease’s Orphanet page. We also link umbrella groups that support undiagnosed and ultra-rare families.
Orphanet entry for X-linked skeletal dysplasia-intellectual disability syndrome — check Associations / patient organisations on that page.
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
"X-linked skeletal dysplasia-intellectual disability syndrome" OR "Christian syndrome" OR "mental retardation-skeletal dysplasia"
ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"X-linked skeletal dysplasia-intellectual disability syndrome" OR "Christian syndrome" OR "mental retardation-skeletal dysplasia"
Study-type breakdown: 0 interventional · 0 observational · 0 expanded access. Only interventional studies enter the trial headline.
Parent-category trials query:
"skeletal dysplasia"
Query health: ok — strategies attempted: phrase; with hits: phrase
Run this search on ClinicalTrials.gov
Confidence reasoning
- Preferred label is multi-word and distinctive
- No synonyms dropped by stoplist
- No label/synonym collisions with other diseases in this corpus
- Publication count (604) is implausibly high for prevalence class "<1 / 1 000 000" — treat as possible over-matching, not a measure of research intensity
Ingested 2026-07-26T17:19:53.347Z
